In substance and timing, AstraZeneca's resolution to cancel a deliberate growth of its flu vaccine facility at Speke is a…
In substance and timing, AstraZeneca's choice to cancel a deliberate enlargement of its flu vaccine facility at Speke is a…
AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a lower in funding from authorities.The funding,…
Sign in to your account